Interviews

GSK CEO Emma Walmsley expressed optimism about the success of the respiratory syncytial virus (RSV) vaccine, Arexvy, anticipating sales surpassing a billion pounds in its debut year. Despite ongoing costly litigation over the discontinued drug Zantac, Walmsley affirmed that the legal expenses wouldn’t disrupt the company’s capital plans. The vaccine, Arexvy, granted approval by the […]

Pharm Madehin, who has already served as the National Treasurer of the Pharmaceutical Society of Nigeria (PSN) for the past three years, has decided to run for the post of National Secretary, driven by his deep commitment to contributing more effectively to the profession. He is confidence in his capacity to continue making valuable contributions […]